Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Operating Expenses (2016 - 2025)

Fortress Biotech (FBIO) has 13 years of Operating Expenses data on record, last reported at $24.4 million in Q3 2025.

  • For Q3 2025, Operating Expenses fell 33.44% year-over-year to $24.4 million; the TTM value through Sep 2025 reached $151.7 million, down 9.98%, while the annual FY2024 figure was $168.1 million, 25.92% down from the prior year.
  • Operating Expenses reached $24.4 million in Q3 2025 per FBIO's latest filing, down from $52.9 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $80.3 million in Q4 2021 and bottomed at $24.4 million in Q3 2025.
  • Average Operating Expenses over 5 years is $54.8 million, with a median of $52.9 million recorded in 2025.
  • Peak YoY movement for Operating Expenses: soared 118.37% in 2021, then tumbled 44.31% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $80.3 million in 2021, then decreased by 11.51% to $71.0 million in 2022, then plummeted by 44.31% to $39.6 million in 2023, then dropped by 1.53% to $39.0 million in 2024, then tumbled by 37.26% to $24.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $24.4 million in Q3 2025, $52.9 million in Q2 2025, and $35.5 million in Q1 2025.